Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01485783 · ClinicalTrials.gov registry record

Improving Outcomes for Hypertensive Children

A clinical trial of Hypertension, sponsored by Arkansas Children's Hospital Research Institute.

Completed
Registry status
112
Enrollment target
1
Study location

NCT01485783 is a study of Hypertension that has completed, run by Arkansas Children's Hospital Research Institute. The registered enrollment target is 112 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01485783, a study of Hypertension, has completed, sponsored by Arkansas Children's Hospital Research Institute.

COMPLETED
Registry status
112 participants
Enrollment target
1
Study location

Study Summary

Approximately 200 children age 6 - \<18 years receiving medications for essential hypertension (HTN) will be recruited from the Pediatric Hypertension Clinic at the time of a routine clinic visit. Participating subjects will be asked to wear the ambulatory blood pressure monitor (ABPM) for 24 hours within 2 weeks of the qualifying visit. Measurements obtained with the ABPM will be compared to measurements obtained by routine clinical procedures documented in the subject's clinical chart. Kappa statistic will be utilized to compare differences in documented BP control between the two measures as well as changes in therapeutic management decisions by treating physicians with the addition of the ABPM readings. The overall goal is to confirm that ABPM leads to an increased detection of uncontrolled HTN along with a similar increase in adjustments increasing anti-hypertensive medication regimens.

Conditions Studied

Study Locations (1)

Arkansas

  • Arkansas Children's Hospital - Little Rock

Trial Details

FieldValue
Enrollment Target 112 participants
Start Date 2011-11
Est. Completion 2015-05

What the Registry Record Tells You About NCT01485783

The ClinicalTrials.gov registry entry for NCT01485783 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 112 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (97% lower). The listed sponsor is Arkansas Children's Hospital Research Institute, which has 97 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hypertension appearing as the primary indexed condition, and to 0 interventions.

NCT01485783 reports 1 study location spanning 1 distinct geographic area - top geographies include Arkansas.

Frequently Asked Questions

What is clinical trial NCT01485783 about?

NCT01485783 is a clinical study titled "Improving Outcomes for Hypertensive Children". Approximately 200 children age 6 - \<18 years receiving medications for essential hypertension (HTN) will be recruited from the Pediatric Hypertension Clinic at the time of a routine clinic visit. Participating subjects will be asked to wear the ambulatory blood pressure monitor (ABPM) for 24 hours ...

What is the current status of trial NCT01485783?

This trial is currently completed. The enrollment target is 112 participants. The study started on 2011-11. Estimated completion is 2015-05.

What conditions does trial NCT01485783 study?

This clinical trial studies the following conditions: Hypertension.

Who is sponsoring clinical trial NCT01485783?

This trial is sponsored by Arkansas Children's Hospital Research Institute, which has 97 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01485783 being conducted?

This trial has 1 study location across Arkansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.